TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Petros Pharmaceuticals ( (PTPI) ) has issued an announcement.
Petros Pharmaceuticals, Inc. announced that its common stock will be delisted from the Nasdaq Stock Market, effective ten days after the filing of Form 25 with the Securities and Exchange Commission. The stock, which was suspended from Nasdaq trading in May 2025, has been trading on the OTCID Basic Market since July 2025 and will continue to do so without disruption, while the company remains subject to certain reporting obligations.
More about Petros Pharmaceuticals
Average Trading Volume: 328,632
Technical Sentiment Signal: Sell
Current Market Cap: $826.3K
Learn more about PTPI stock on TipRanks’ Stock Analysis page.